Systemic hypertension. Part 2: Diagnosis mid treatment

被引:0
|
作者
Savary-Bataille, K
机构
来源
PRATIQUE MEDICALE ET CHIRURGICALE DE L ANIMAL DE COMPAGNIE | 2002年 / 37卷 / 04期
关键词
systemic hypertension; dogs; cats; ultrasonic (doppler) method; oscillometric method; angiotensin converting enzyme inhibitor; calcium channel blocker;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
In small animals, systemic hypertension occurs most often secondary to renal disorders (chronic renal failure) or endocrinopathies, and manifests itself by ocular, neurological, cardiac and renal symptoms. After clinical suspicion of systemic hypertension or in case of renal or endocrine diseases, final diagnosis relies upon indirect blood pressure measurement by ultrasonic (cat and dog) or oscillometric (dog) method. Treatment should be instituted after recognition of compatible clinical signs and confirmation of a persistently elevated blood pressure. It includes dietary, etiological (treatment of the underlying disease) and specific measures. Major antihypertensive drugs include angiotensin converting enzyme inhibitors, used primarily in dogs, and calcium channel blockers, used in cats.
引用
收藏
页码:261 / 267
页数:7
相关论文
共 50 条
  • [31] Ocular hypertension. Treatment: Yes or no? [Okuläre Hypertension. Behandeln: Ja oder Nein?]
    Hommer A.
    Resch H.
    Spektrum der Augenheilkunde, 2007, 21 (2) : 114 - 117
  • [32] Cardiovascular risk and individualised treatment of hypertension.
    Colombet, I
    Chatellier, G
    Jaulent, MC
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 2000, 93 (11): : 1400 - 1403
  • [33] Invasive treatment of hypertension. Update 2016
    Menne, J.
    Wachter, R.
    INTERNIST, 2016, 57 (09): : 871 - 878
  • [34] The role of diet in the prevention and treatment of hypertension.
    Appel L.J.
    Current Atherosclerosis Reports, 2000, 2 (6) : 521 - 528
  • [35] Valsartan in the treatment of mild to moderate hypertension.
    Ascioti, C
    Ferlaino, G
    AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (04) : 131A - 131A
  • [36] Optimization of antihypertensive treatment in essential hypertension.
    Román, O
    Badilla, M
    Valenzuela, MA
    Baez, D
    Herrera, E
    HYPERTENSION, 2001, 37 (03) : 1035 - 1035
  • [37] 2013 Korean Society of Hypertension guidelines for the management of hypertension. Part II—treatments of hypertension
    Jinho Shin
    Jeong Bae Park
    Kwang-il Kim
    Ju Han Kim
    Dong Heon Yang
    Wook Bum Pyun
    Young Gweon Kim
    Gheun-Ho Kim
    Shung Chull Chae
    Clinical Hypertension, 21 (1)
  • [38] Treatment resistant hypertension. Value of a new treatment concept
    Siekierka-Harreis, M.
    Rump, L. C.
    Vonend, O.
    INTERNIST, 2012, 53 (12): : 1411 - +
  • [39] Eplerenone nanoemulsions for treatment of hypertension. Part I: Experimental design for optimization of formulations and physical characterization
    Ozdemir, Samet
    Celik, Burak
    Acar, Ebru Turkoz
    Duman, Gulengul
    Uner, Melike
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 45 : 357 - 366
  • [40] COMPUTER-AIDED MEDICAL DIAGNOSIS: RHYP3 - A CAUSAL MODEL OF THE DIAGNOSIS AND TREATMENT OF RENOVASCULAR HYPERTENSION.
    Smith Jr., Kime H.
    1977, : 208 - 214